drug

Neurofeedback

MeSH D058765
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by RWTH Aachen University
3 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

3
A Neurofeedback Intervention to Improve Working Memory in Schizophrenia
NCT03260257—Completed
Symptom Based Treatment Affects Brain Plasticity - Cognitive Training in Patients With Affective Symptoms
NCT03183947—Completed
Symptom Based Treatment Affects Brain Plasticity - the Role of Verbal Auditory Hallucinations
NCT02722915—Completed

KOLs & investigators

1
Klaus Mathiak, Prof MD PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
RWTH Aachen University
company
trial
A Neurofeedback Intervention to Improve Working Memory in Schizophrenia
NA
trial
Symptom Based Treatment Affects Brain Plasticity - Cognitive Training in Patients With Affective Symptoms
NA
trial
Symptom Based Treatment Affects Brain Plasticity - the Role of Verbal Auditory Hallucinations
NA
trial
indication
Schizophrenia
indication
Hallucinations, Verbal Auditory
indication
Depression
indication
Emotional Regulation
indication
KOL
Klaus Mathiak, Prof MD PhD
KOL score —
person